BRIEF published on 06/03/2024 at 07:35, 10 months 19 days ago GenSight Biologics accueille William Monteith au Conseil d’administration Conseil D’administration Nomination GenSight Biologics Thérapies Géniques William Monteith
PRESS RELEASE published on 06/03/2024 at 07:30, 10 months 19 days ago Informations privilégiées / Autres communiqués GenSight Biologics nomme William Monteith à son Conseil d'administration. Monteith apportera son expertise en fabrication de thérapies géniques pour soutenir les progrès de l'entreprise Conseil D'administration Fabrication GenSight Biologics Thérapies Géniques William Monteith
BRIEF published on 05/23/2024 at 11:40, 10 months 30 days ago Franchissement de seuils pour GENSIGHT BIOLOGICS S.A. Actions Franchissement De Seuils Bons De Souscription GenSight Biologics Armistice Capital
BRIEF published on 05/23/2024 at 11:40, 10 months 30 days ago Crossing thresholds for GENSIGHT BIOLOGICS SA Actions Crossing Thresholds GenSight Biologics Armistice Capital Subscription Warrants
PRESS RELEASE published on 05/23/2024 at 11:35, 10 months 30 days ago Franchissement de seuils Déclaration de franchissement de seuils par Armistice Capital, LLC concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris Euronext Paris Franchissement De Seuils Armistice Capital LLC GENSIGHT BIOLOGICS SA Déclaration Régularisation
BRIEF published on 05/07/2024 at 19:34, 11 months 15 days ago GenSight Biologics annonce la mise à disposition d'un prospectus pour la cotation de nouvelles actions sur Euronext Paris Euronext Paris Augmentation De Capital Thérapie Génique Prospectus Produits Biologiques GenSight
BRIEF published on 05/07/2024 at 19:34, 11 months 15 days ago GenSight Biologics Announces Availability of Prospectus for New Shares Listing on Euronext Paris Euronext Paris Capital Increase Gene Therapy Prospectus GenSight Biologics
PRESS RELEASE published on 05/07/2024 at 19:29, 11 months 15 days ago Modalités de mise à disposition de prospectus GenSight Biologics annonce la mise à disposition d'un prospectus pour l'admission d'actions nouvelles sur Euronext Paris. La société spécialisée dans les thérapies géniques pour les maladies neurodégénératives informe sur le processus Euronext Paris Prospectus GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
PRESS RELEASE published on 05/07/2024 at 19:29, 11 months 15 days ago Terms of availability of prospectuses GenSight Biologics announces availability of listing prospectus for new shares on Euronext Paris. The prospectus approved by AMF includes universal registration document, securities note, and summary Euronext Paris New Shares AMF Approval GenSight Biologics Listing Prospectus
Published on 04/22/2025 at 19:55, 3 hours 15 minutes ago CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape
Published on 04/22/2025 at 19:45, 3 hours 25 minutes ago NewsOut Launches Weekly Video Press Release Coverage on Tesla, Amazon, Apple, NVIDIA, and Microsoft
Published on 04/22/2025 at 15:45, 7 hours 25 minutes ago Alaska Energy Metals Files Updated NI 43-101 Technical Report for The Eureka Deposit, Nikolai Nickel Project, Alaska, USA
Published on 04/22/2025 at 15:15, 7 hours 55 minutes ago Silver Bull Announces Voting Results of Annual Meeting of Shareholders
Published on 04/22/2025 at 15:15, 7 hours 55 minutes ago D. Boral Capital Acted as Exclusive Placement Agent to Safe & Green Holdings Corp. (Nasdaq: SGBX) in Connection with Its Approximately $8.0 Million Private Placement
Published on 04/22/2025 at 22:26, 43 minutes ago EQS-Adhoc: Allane SE: Deviation of earnings forecast for financial year 2024, postponement of publication of annual and consolidated financial statements and AGM, no dividend distribution for 2024
Published on 04/22/2025 at 22:05, 1 hour 5 minutes ago Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Published on 04/22/2025 at 22:05, 1 hour 5 minutes ago Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Published on 04/22/2025 at 22:00, 1 hour 10 minutes ago Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Published on 04/22/2025 at 22:00, 1 hour 10 minutes ago Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Published on 04/22/2025 at 18:13, 4 hours 56 minutes ago ELECTRICITE DE STRASBOURG - Droits de vote au jour de l'avis de réunion de l'AGO du 14 mai 2025
Published on 04/22/2025 at 18:12, 4 hours 57 minutes ago ELECTRICITE DE STRASBOURG - Avis de mise à disposition des rapports 2024, des rapports des CAC et des états financiers
Published on 04/22/2025 at 17:57, 5 hours 13 minutes ago NRJ Group - AGM 15 mai 2025 - Mise à disposition des documents préparatoires
Published on 04/22/2025 at 17:57, 5 hours 13 minutes ago Annual Shareholders' Meeting 2025 - Conditions of availability of the preparatory documents
